downloadDownload file

downloadDownload file

1/1

2 files

Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections

figure

posted on 02.10.2020, 15:27 by Tanaya Bhowmick, Melvin P. Weinstein

The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

https://link.springer.com/article/10.1007/s40121-020-00350-1

Usage metrics

Read the peer-reviewed publication

Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections

Infectious Diseases and Therapy

Infectious Diseases and Therapy

Categories

Keywords

B-lactam- B-lactamase inhibitor CRE Meropenem-vaborbactam Plain Language Summary

Licence

Exports